Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,336 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety verification trials of mFOLFIRI and sequential IRIS + bevacizumab as first- or second-line therapies for metastatic colorectal cancer in Japanese patients.
Kato S, Andoh H, Gamoh M, Yamaguchi T, Murakawa Y, Shimodaira H, Takahashi S, Mori T, Ohori H, Maeda S, Suzuki T, Kato S, Akiyama S, Sasaki Y, Yoshioka T, Ishioka C; Tohoku Clinical Oncology Research and Education. Kato S, et al. Among authors: yoshioka t. Oncology. 2012;83(2):101-7. doi: 10.1159/000339541. Epub 2012 Jul 9. Oncology. 2012. PMID: 22777333 Clinical Trial.
Phase II study of trifluridine/tipiracil (TAS-102) therapy in elderly patients with colorectal cancer (T-CORE1401): geriatric assessment tools and plasma drug concentrations as possible predictive biomarkers.
Takahashi M, Sakamoto Y, Ohori H, Tsuji Y, Kuroki M, Kato S, Otsuka K, Komine K, Takahashi M, Takahashi S, Shirota H, Ouchi K, Takahashi Y, Imai H, Shibata H, Yoshioka T, Tanaka M, Yamaguchi H, Yamaguchi T, Shimodaira H, Ishioka C. Takahashi M, et al. Among authors: yoshioka t. Cancer Chemother Pharmacol. 2021 Sep;88(3):393-402. doi: 10.1007/s00280-021-04277-3. Epub 2021 May 24. Cancer Chemother Pharmacol. 2021. PMID: 34028598 Free PMC article. Clinical Trial.
Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation.
Yoshioka T, Sakayori M, Kato S, Chiba N, Miyazaki S, Nemoto K, Shibata H, Shimodaira H, Ohtsuka K, Kakudo Y, Sakata Y, Ishioka C. Yoshioka T, et al. Int J Clin Oncol. 2006 Dec;11(6):454-60. doi: 10.1007/s10147-006-0610-5. Epub 2006 Dec 25. Int J Clin Oncol. 2006. PMID: 17180514
[Clinical characteristics of cancer of unknown primary (CUP)--a summary of 22 cases].
Kato S, Yasuda K, Nishino Y, Ohori H, Takahashi M, Takahashi S, Yamaura G, Ohtsuka K, Kakudo Y, Chiba N, Shimodaira H, Sakayori M, Kato S, Suzuki T, Murakawa Y, Gamoh M, Shibata H, Yoshioka T, Ishioka C. Kato S, et al. Among authors: yoshioka t. Gan To Kagaku Ryoho. 2007 Aug;34(8):1227-31. Gan To Kagaku Ryoho. 2007. PMID: 17687203 Japanese.
Intermittent Withdrawal of Oxaliplatin for Alleviating Neurotoxicity during Oxaliplatin-Based Chemotherapy for Japanese Patients with Inoperable or Metastatic Colorectal Cancer: A Phase 2 Multicenter Study.
Kato S, Imai H, Gamoh M, Takahata T, Ohori H, Yasuda K, Niitani T, Murakawa Y, Amagai K, Isobe H, Shindo Y, Kuroki M, Sakamoto Y, Shimodaira H, Yoshioka T, Ishioka C. Kato S, et al. Among authors: yoshioka t. Tohoku J Exp Med. 2018 May;245(1):21-28. doi: 10.1620/tjem.245.21. Tohoku J Exp Med. 2018. PMID: 29743448 Free article. Clinical Trial.
2,336 results